Discover insights from Autolus Therapeutics' Q2 2025 earnings call. Explore revenue growth, AUCATZYL expansion, and strategic plans for U.S. and EU markets.

Q2 2025 net revenue of $25.9 million, driven by product net revenue of $21.8 million Completed sale of PRV for $150.0 million, bolstering the balance sheet as the Company executes on its commercial ...

Inspection certification firm Eurofins Sustainability Services has added a new tool for verifying cotton origin, called ...

Today's powerful AI models are smart enough to predict the real reaction of users to OpenAI switch to a single model, ChatGPT ...

D printing company 3D Systems (NYSE:DDD) in Q2 CY2025, with sales falling 16.3% year on year to $94.84 million. Its non-GAAP ...

Grounded 2 is also a change in how Obsidian works; the studio tapped Eidos, known for its work on the modern Deus Ex games ...

Boasting a barely-there feel and colour-correcting pigment, this tinted SPF has earned pride of place in my minimal holiday ...

Humacyte shares plummeted 30% following its second-quarter earnings report. Check out what prompted me to maintain my Sell ...

Auxy Studio is one of our favourite music-making apps for iOS. Launched in 2014, it offered users a simple, uncluttered ...

Huawei Mate XT 2 is reportedly going to launch on September 10, the same day as the iPhone 17 series. This is going to be a ...

A major milestone has been achieved for the Autonomous Multi-Domain Launcher as it moves toward augmenting — and possibly ...

This week brings the launch of a fresh rolling carry-on tote from Hulken, a Lego recreation of an Italian Riviera and an ...